Cargando…

Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment

BACKGROUND: Breast cancer is by far the most frequent cancer among women. The proliferative index, Ki-67, is more and more taken into consideration for treatment decisions. However, the reliability of the established Ki-67 scoring is limited. Digital pathology is currently suggested to be a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayad, Essam, Soliman, Ahmed, Anis, Shady Elia, Salem, Amira Ben, Hu, Pengchao, Dong, Youhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114705/ https://www.ncbi.nlm.nih.gov/pubmed/30153851 http://dx.doi.org/10.1186/s13000-018-0735-7

Ejemplares similares

Quantitative assessment of Ki67 expression in correlation with various breast cancer characteristics and survival rate; cross sectional study
por: Mohammed, Ayad Ahmad
Publicado: (2019)

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
por: Luchini, Claudio, et al.
Publicado: (2022)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

Visual and digital assessment of Ki-67 in breast cancer tissue - a comparison of methods
por: Skjervold, Anette H., et al.
Publicado: (2022)

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer
por: Konsti, Juho, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

A novel model for Ki67 assessment in breast cancer
por: Romero, Quinci, et al.
Publicado: (2014)

An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
por: Shui, Ruohong, et al.
Publicado: (2015)

Assessment of Ki-67 as a potential biomarker in patients with breast cancer
por: Ragab, Halla Mohamed, et al.
Publicado: (2018)

Cytohistological correlation in pituitary tumor and immunological assessment with the help of Ki-67
por: Sen, A, et al.
Publicado: (2017)

A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer
por: Zhong, Fangfang, et al.
Publicado: (2016)

Comparison Between Manual and Automated Assessment of Ki-67 in Breast Carcinoma: Test of a Simple Method in Daily Practice
por: Catteau, Xavier, et al.
Publicado: (2023)

Ki‐67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma
por: Rigillo, Antonella, et al.
Publicado: (2021)

Automated assessment of Ki‐67 proliferation index in neuroendocrine tumors by deep learning
por: Vesterinen, Tiina, et al.
Publicado: (2021)

Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation
por: Kadivar, Maryam, et al.
Publicado: (2020)

Quantitative parameters in novel spectral computed tomography: Assessment of Ki-67 expression in patients with gastric adenocarcinoma
por: Mao, Li-Ting, et al.
Publicado: (2023)

Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67.
por: Brown, D. C., et al.
Publicado: (1988)

The Relevance of Assessing the Cell Proliferation Factor Ki-67 in Squamous Cell Carcinoma of the Larynx
por: Vukelic, J., et al.
Publicado: (2019)

Assessment of Expression of Ki-67 in Benign and Malignant Prostatic Lesions among Sudanese Patients
por: Mohamed, Albasheer Abdelmalik, et al.
Publicado: (2018)

Assessment of Ki-67 proliferation index with deep learning in DCIS (ductal carcinoma in situ)
por: Fulawka, Lukasz, et al.
Publicado: (2022)

Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index
por: Lea, Dordi, et al.
Publicado: (2021)

Differential Expression of Glypican-3 and Insulin–Like Growth Factor-II mRNAs and Alpha-Fetoprotein and Ki-67 Markers in HCV Related Hepatocellular Carcinomas In Egyptian Patients
por: Saber, Mohamed A, et al.
Publicado: (2017)

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
por: Kwon, Ah-Young, et al.
Publicado: (2019)

The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index
por: Arima, Nobuyuki, et al.
Publicado: (2016)

The value of the FDG-GaTate and proliferation marker (ki-67) in the assessment of neuroendocrine tumours (NETs)
por: Fikri, AS Fathinul, et al.
Publicado: (2015)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

An interobserver reproducibility analysis of size-set semiautomatic counting for Ki67 assessment in breast cancer
por: Wang, Yi-xing, et al.
Publicado: (2019)

Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation
por: Ghosh, Apurv, et al.
Publicado: (2020)

The predictive value of energy spectral CT parameters for assessing Ki-67 expression of lung cancer
por: Dou, Peipei, et al.
Publicado: (2020)

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

Comparison between Manual and Automated Methods for Ki-67 Immunoexpression Quantification in Ameloblastomas
por: González-González, Rogelio, et al.
Publicado: (2016)

Assessment of the predictive role of pretreatment Ki-67 and Ki-67 changes in breast cancer patients receiving neoadjuvant chemotherapy according to the molecular classification: a retrospective study of 1010 patients
por: Chen, Rui, et al.
Publicado: (2018)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

The assessment of Ki-67 for prognosis of gastroenteropancreatic neuroendocrine neoplasm patients: a systematic review and meta-analysis
por: Tao, Zhiwei, et al.
Publicado: (2023)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
por: Nielsen, Ljudmilla A. G., et al.
Publicado: (2018)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_15j26is6nl4nlrh09kv9nmsjs2